Company

Gallant

Biotechnology Research 10865 Road to the Cure 63 employees

Employees: 63
Contacts: 3
Emails: 3
Phones: 2

www.gallant.com LinkedIn

Gallant Overview

Headquarters: 10865 Road to the Cure
Website: www.gallant.com
Industry: Biotechnology Research
Employees: 63
Founded: 2018
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotechnology Research

About Gallant

Gallant is an animal health biotechnology company pioneering "ready-to-use" stem cell therapies for pets. Gallant's pipeline of off-the-shelf mesenchymal stem cell (MSC) therapies address conditions in dogs and cats—including feline chronic gingivostomatitis (FCGS), osteoarthritis, chronic kidney disease, and atopic dermatitis. Our first product, based on a proprietary uterine-derived stem cell platform, is on track for conditional FDA approval in 2026. Led by industry pioneers in veterinary regenerative medicine, Gallant combines science, purpose, and compassion to help pets live healthier, more vibrant lives.

Gallant Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

Gallant Org Chart

Sample employees and titles

Name	Title	Location	Contact
Orzala Sharif	Flow Cytometry Specialist at Gallant	San Diego, California, United States	Email
Carolyn Wrightson, Phd			View
Aaron Schacht	CEO & Board Director @ Biomedit - Biotechnology Innovation	Greater Indianapolis, United States	Email Phone
Richard Jennings		Los Angeles Metropolitan Area, United States	Email Phone